Sign inCreate Account
The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
NEWS
BUSINESS
MOVIES
CRICKET
SPORTS
GET AHEAD
REDIFF MONEY
REDIFF-TV
REDIFF ASTRO